1,035 recalls tagged with “chemical hazard”.
Glenmark Pharmaceuticals recalled 17,496 bottles of Carvedilol Tablets on August 6, 2025. Tests revealed N-Nitroso Carvedilol Impurity-1 levels exceeded FDA limits. Consumers should stop using the medication immediately.
Glenmark Pharmaceuticals recalled 14,976 bottles of Carvedilol Tablets on August 6, 2025. The recall follows findings of N-Nitroso Carvedilol Impurity-1 above FDA limits. Consumers should stop using the product immediately and contact their healthcare provider.
M.O.M Enterprises recalled 85,248 units of its Organic BABY bedtime drops due to potential yeast contamination. The recall affects two lots sold nationwide since August 2025. Consumers should stop using the product immediately and seek a refund.
B. Braun Medical Inc. recalled 23,100 containers of 0.9% Sodium Chloride Injection on August 4, 2025. The recall stems from a lack of assurance of sterility and potential fluid leakage. This product is distributed nationwide in the United States.
Hospira, Inc. recalled 15,750 vials of Sodium Bicarbonate Injection on August 4, 2025. The recall stems from a lack of assurance of sterility. Consumers and healthcare providers must stop using the product immediately.
Neuhaus nv recalled 100 pieces of ORIGINAL BELGIAN CHOCOLATE on August 4, 2025, due to undeclared wheat. The recall affects products distributed in Virginia, Maryland, Pennsylvania, New York, and Washington D.C.
Hospira, Inc. recalled 49,620 vials of Epinephrine Injection on August 4, 2025. The recall follows concerns about the lack of assurance of sterility. Consumers should stop using the product immediately.
B. Braun Medical Inc. recalled 74,088 containers of Lactated Ringer's Injection on August 4, 2025. The recall stems from a lack of assurance of sterility and potential fluid leakage. Consumers and healthcare providers should discontinue use immediately and seek guidance.
Medline Industries recalled 7,913 reprocessed electrophysiology catheters on July 31, 2025. Residual particulates on patient-contacting surfaces pose a risk of serious infection and thrombus formation. Patients and healthcare providers must stop using these devices immediately.
Medline Industries recalled 7,913 electrophysiology catheters on July 31, 2025, due to contamination concerns. Specific lots may contain small residual particulates, posing risks of systemic infection and thrombus formation. Patients and healthcare providers should stop using these devices immediately.
Exela Pharma Sciences recalled 4.2% Sodium Bicarbonate Injection on July 30, 2025, due to arsenic contamination. The recall affects single-dose vials distributed nationwide. Consumers and healthcare providers must stop using the product immediately.
S.I.N. Implant System Ltda recalled 4,367 dental implants on July 30, 2025, due to improper storage conditions. The recalled products may have compromised packaging, affecting their quality and performance. Patients and healthcare providers should stop using these devices immediately.
American Health Packaging recalled 26,992 blister packs of Sucralfate Tablets on July 29, 2025. The recall follows CGMP deviations that affect product quality. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Pfizer Inc. recalled 29,004 bottles of Levoxyl on July 29, 2025, due to subpotency. The recall affects levothyroxine sodium tablets, 50 mcg, Rx only, distributed in the U.S. Consumers should stop using the product immediately.
Dynamic Sports Nutrition recalled 1,566 bottles of WINN-50 dietary supplement on July 28, 2025. The product contains sub-potent levels of Vitamin B12, failing to meet label claims. Consumers should stop using the product immediately and seek refunds.
Gelson's recalled 7,861 units of Red Bell Pepper Hummus on July 25, 2025. Labels failed to include critical storage instructions to keep refrigerated. Consumers should not consume the product and seek refunds.
Gelson's recalled 7,861 units of its Low Sodium No Cholesterol Classic Hummus on July 25, 2025. The product labels fail to include essential storage instructions to keep refrigerated. Consumers should not consume the product and seek a refund.
Towa Pharmaceutical Europe recalled 1,856 bottles of Duloxetine delayed-release capsules on July 25, 2025. The recall follows the discovery of N-nitroso-duloxetine impurity exceeding FDA limits. Consumers should stop using the product immediately and seek guidance.
Cipla USA, Inc. recalled 20,352 packs of Albuterol Sulfate inhalation aerosol on July 24, 2025. The recall follows out-of-specification results in particle size distribution during stability testing. Consumers must stop using the product immediately.
Diamond G Forest Products recalled turpentine bottles on July 24, 2025, due to a risk of child poisoning. The 4-ounce glass bottles lack child-resistant packaging, violating safety standards. The recall affects an unspecified number of bottles sold nationwide.